title: Possible role for human leukocyte antigen haplotype in rofecoxib-associated acute pancreatitis and cholestatic hepatitis.
authors.forename: Ken
authors.initials: K
authors.lastname: Sato
authors.forename: Eijirou
authors.initials: E
authors.lastname: Yamada
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Uehara
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Takagi
authors.forename: Masatomo
authors.initials: M
authors.lastname: Mori
mesh_terms: D000368:Aged; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000235:genetics; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006680:HLA Antigens / Q000235:genetics*; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy; D019283:Pancreatitis, Acute Necrotizing / Q000139:chemically induced* / Q000235:genetics; D013450:Sulfones / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D006680:HLA Antigens; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib